I) Introduction
The science of biochemicals and the realm of Section 3(d) of Indian Patents Act!
Can there be a reconciliation between the two?
This question is a hot topic of discussion amongst the…
A judicial and academic debate on standard essential patents (SEPs) in China has recently arisen. The issuance of anti-suit injunctions (ASIs) by Chinese courts in a relatively short period of time (…
This is the first of a new series of monthly posts on the UPC from Bristows, in which our UPC experts will be providing their commentary and insights on the development and themes arising from the…
In April 2023, the European Commission (EC) published the pharmaceutical legislation package, including the proposal for a Pharmaceutical Directive[1] , and further proposals for regulations on SPCs[…
On 25 October 2023, HHJ Hacon (sitting as a High Court Judge), rendered his judgment in Philip Morris v Nicoventures[1]. The Claimants (“PMI”) sought revocation of EP (UK) No. 3 367 830 B1 (“EP 830…
The political environment at the EPO remains bumpy. Though some progress is made in relatively minor adjustments of the working conditions, the SUEPO trade union and staff committees remain largely…
...well, at least the EPO's Boards of Appeal, represented by their President Mr. Josefsson, are.
Mr. Josefsson announced in the Boards of Appeal and key decisions 2023 conference just a few minutes…
On October 24, 2023, the Brazilian government released an Action Plan aiming at fostering the National Intellectual Property (IP) Strategy. The plan was prepared by the Interministry IP Group ( a…
A sweeping reform of the European Union’s legislation on supplementary protection certificates for medicinal products and plant protection products is currently underway, which features the…
A hefty judgment was recently handed down by Mellor J concerning a patent for a modified release formulation of mirabegron. The patent was held to be valid and not infringed by Sandoz, while…
